• 922 Citations
  • 16 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where L. Wágner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 30 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 922 Citations
  • 16 h-Index
  • 51 Article
  • 3 Review article
  • 2 Letter
  • 1 Comment/debate

Reduced O-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney

Hodrea, J., Balogh, D. B., Hosszu, A., Lenart, L., Besztercei, B., Koszegi, S., Sparding, N., Genovese, F., Wagner, L. J., Szabo, A. J. & Fekete, A., ápr. 1 2020, In : American journal of physiology. Renal physiology. 318, 4, p. F1017-F1029

Research output: Article

Open Access
  • Oncological Screening of Kidney Transplant Patients: The Role of Ultrasound Examination

    Kiss, G., Korda, D., Szabó, G., Juhász, R., Wágner, L., Máthé, Z., Doros, A. & Végső, G., máj. 1 2019, In : Transplantation Proceedings. 51, 4, p. 1231-1233 3 p.

    Research output: Article

  • RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition

    Koszegi, S., Molnar, A., Lenart, L., Hodrea, J., Balogh, D. B., Lakat, T., Szkibinszkij, E., Hosszu, A., Sparding, N., Genovese, F., Wagner, L., Vannay, A., Szabo, A. J. & Fekete, A., jan. 1 2019, In : Journal of Physiology. 597, 1, p. 193-209 17 p.

    Research output: Article

  • 6 Citations (Scopus)